Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study

M. Vaes, D. Bron, D.J. Vugts, M. Paesmans, M. Meuleman, G. Ghanem, T. Guiot, B. Vanderlinden, K. Thielemans, G.A.M.S. van Dongen, P. Flamen, K. Muylle

Research output: Contribution to journalArticleAcademic

82 Downloads (Pure)
Original languageEnglish
Pages (from-to)394-400
JournalJournal of Cancer Science & Therapy
Issue number12
Publication statusPublished - 2012

Cite this